Journal
ONCOGENE
Volume 36, Issue 10, Pages 1351-1363Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/onc.2016.299
Keywords
-
Funding
- National Basic Research Program of China [2012CBA01302]
- National Natural Science Foundation of China [81425016, 81270646]
- Natural Science Foundation of Guangdong Province [S2013030013305, S20120011190, 2015A030312013]
- Key Scientific and Technological Projects of Guangdong Province [2014B020226002, 2015B020226004, 2014B020228003, 2015B020228001]
- Key Scientific and Technological Program of Guangzhou City [201400000003-3, 201508020262, 201300000089]
- Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (GDUPS)
Ask authors/readers for more resources
Colorectal cancer (CRC) is one of the top three most prevalent and deadly cancers. A cancer stem cell (CSC) sub-population that is characterized by the abilities of tumor initiation, self-renewal, metastasis and resistance to chemotherapy can suggest new therapeutic targets. However, no such sub-population has been conclusively identified for CRC, and we lack any marker to identify cells with all of the above characteristics. Here, we report that CD51(+) CRC cells displayed greater sphere-forming and tumorigenic capacities, increased migratory and invasive potentials, and enhanced chemoresistance compared with CD51(-) CRC cells. CD51 knockdown reduced the side population, sphere formation, cell motility and inhibited tumor incidence and metastasis in an in vivo tumor model. Furthermore, CD51 could bind transforming growth factor beta (TGF-beta) receptors, and that it upregulated TGF-beta/Smad signaling. These results indicate that CD51 is a novel functional marker for colorectal CSCs which may provide an therapeutic target for the efficient elimination of colorectal CSCs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available